Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer.

MLA

Ikeda, Hirokuni, et al. “Combination Treatment with Fulvestrant and Various Cytotoxic Agents (Doxorubicin, Paclitaxel, Docetaxel, Vinorelbine, and 5-Fluorouracil) Has a Synergistic Effect in Estrogen Receptor-Positive Breast Cancer.” Cancer Science, vol. 102, no. 11, Nov. 2011, pp. 2038–42. EBSCOhost, https://doi.org/10.1111/j.1349-7006.2011.02050.x.

APA

Ikeda, H., Taira, N., Nogami, T., Shien, K., Okada, M., Shien, T., Doihara, H., & Miyoshi, S. (2011). Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer. Cancer Science, 102(11), 2038–2042. https://doi.org/10.1111/j.1349-7006.2011.02050.x

Chicago

Ikeda, Hirokuni, Naruto Taira, Tomohiro Nogami, Kazuhiko Shien, Masanori Okada, Tadahiko Shien, Hiroyoshi Doihara, and Shinichiro Miyoshi. 2011. “Combination Treatment with Fulvestrant and Various Cytotoxic Agents (Doxorubicin, Paclitaxel, Docetaxel, Vinorelbine, and 5-Fluorouracil) Has a Synergistic Effect in Estrogen Receptor-Positive Breast Cancer.” Cancer Science 102 (11): 2038–42. doi:10.1111/j.1349-7006.2011.02050.x.